Johnson & Johnson (JNJ) Earnings Date, Estimates & Call Transcripts $156.76 +0.36 (+0.23%) (As of 02/9/2024 08:56 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateApr. 16EstimatedActual EPS (Jan. 23) $2.29 Beat By $0.01 Consensus EPS (Jan. 23) $2.28 Read Call TranscriptListen to Call Get Johnson & Johnson Earnings AlertsEnter your email address below to receive the latest news and earnings results for JNJ and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueJNJ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.JNJ Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Johnson & Johnson Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$2.59$2.78$2.66 Q2 20243$2.72$2.87$2.78 Q3 20243$2.65$2.92$2.77 Q4 20243$2.53$2.80$2.66 FY 202412$10.49$11.37$10.87 Q1 20251$2.62$2.62$2.62 Q2 20251$2.75$2.75$2.75 Q3 20251$2.72$2.72$2.72 Q4 20251$2.75$2.75$2.75 FY 20254$10.84$10.84 $10.84JNJ Earnings Date and InformationJohnson & Johnson last announced its earnings data on January 23rd, 2024. The reported $2.29 earnings per share for the quarter, beating the consensus estimate of $2.28 by $0.01. The company earned $21.40 billion during the quarter, compared to the consensus estimate of $21.02 billion. Its revenue for the quarter was down 9.7% on a year-over-year basis. Johnson & Johnson has generated $13.81 earnings per share over the last year ($13.81 diluted earnings per share) and currently has a price-to-earnings ratio of 11.4. Earnings for Johnson & Johnson are expected to grow by 3.00% in the coming year, from $10.65 to $10.97 per share. Johnson & Johnson has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 16th, 2024 based off prior year's report dates.Read More Johnson & Johnson Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/16/2024Estimated)------- 1/23/2024Q4 2023$2.28$2.29+$0.01$2.91$21.02 billion$21.40 billion 10/17/2023Q3 2023$2.52$2.66+$0.14($4.89)$21.00 billion$21.35 billion7/20/2023Q2 2023$2.62$2.80+$0.18$3.64$24.63 billion$25.53 billion 4/18/2023Q1 2023$2.51$2.68+$0.17$5.39$23.61 billion$24.75 billion 1/24/2023Q4 2022$2.22$2.35+$0.13$3.37$23.90 billion$23.71 billion 10/18/2022Q3 2022$2.49$2.55+$0.06$3.42$23.44 billion$23.79 billion Get the Latest News and Ratings for JNJ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter. 7/19/2022Q2 2022$2.57$2.59+$0.02$3.38$23.85 billion$24.02 billion 4/19/2022Q1 2022$2.60$2.67+$0.07$3.41$23.62 billion$23.43 billion 1/25/2022Q4 2021$2.12$2.13+$0.01$2.49$25.29 billion$24.80 billion 10/18/2021Q3 2021$2.35$2.60+$0.25$3.83$23.72 billion$23.34 billion 7/20/2021Q2 2021$2.29$2.48+$0.19$2.61$22.54 billion$23.31 billion 4/19/2021Q1 2021$2.34$2.59+$0.25$2.86$22.00 billion$22.30 billion Johnson & Johnson Earnings - Frequently Asked Questions When is Johnson & Johnson's earnings date? Johnson & Johnson has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 16th, 2024 based off last year's report dates. Learn more on JNJ's earnings history. Did Johnson & Johnson beat their earnings estimates last quarter? In the previous quarter, Johnson & Johnson (NYSE:JNJ) reported $2.29 earnings per share (EPS) to beat the analysts' consensus estimate of $2.28 by $0.01. Learn more on analysts' earnings estimate vs. JNJ's actual earnings. How can I listen to Johnson & Johnson's earnings conference call? The conference call for Johnson & Johnson's latest earnings report can be listened to online. Listen to Conference Call How can I read Johnson & Johnson's conference call transcript? The conference call transcript for Johnson & Johnson's latest earnings report can be read online. Read Transcript How much revenue does Johnson & Johnson generate each year? Johnson & Johnson (NYSE:JNJ) has a recorded annual revenue of $85.16 billion. How much profit does Johnson & Johnson generate each year? Johnson & Johnson (NYSE:JNJ) has a recorded net income of $35.15 billion. JNJ has generated $13.81 earnings per share over the last four quarters. What is Johnson & Johnson's price-to-earnings ratio? Johnson & Johnson (NYSE:JNJ) has a trailing price-to-earnings ratio of 11.35 and a forward price-to-earnings ratio of 14.72. The price/earnings-to-growth ratio is 2.63. What is Johnson & Johnson's EPS forecast for next year? Johnson & Johnson's earnings are expected to grow from $10.65 per share to $10.97 per share in the next year, which is a 3.00% increase. More Earnings Resources from MarketBeat Related Companies: Merck & Co., Inc. Earnings AbbVie Earnings Pfizer Earnings Bristol-Myers Squibb Earnings Eli Lilly and Company Earnings Novo Nordisk A/S Earnings AstraZeneca Earnings Abbott Laboratories Earnings Sanofi Earnings Vertex Pharmaceuticals Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Airbnb stock bulls just went all in before earningsBeyond Nvidia: The hidden stars with 200% earnings growthArm Holdings: Earnings strength as clouds gather on the horizonS&P 500 rockets to new highs as earnings beat estimatesWhy H&R Block Stock Looks More Attractive After Earnings DipAlibaba stock earnings are out, everything just changed5 medical stocks growing earnings by triple digits This page (NYSE:JNJ) was last updated on 2/12/2024 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.